ANTI-OXIDATIVE, ANTI-INFLAMMATORY AND ANTI-ATHEROSCLEROTIC EFFECT OF TAURINE ON HYPERCHOLESTEROLEMIA INDUCED ATHEROSCLEROTIC RATS by Sharma, Harsha et al.
 
Original Article 
ANTI-OXIDATIVE, ANTI-INFLAMMATORY AND ANTI-ATHEROSCLEROTIC EFFECT OF 
TAURINE ON HYPERCHOLESTEROLEMIA INDUCED ATHEROSCLEROTIC RATS 
 
HARSHA SHARMAa*, ANKITA JOSHIa, HARSHA LADa, DEEPAK BHATNAGARa 
aSchool of Biochemistry, Devi Ahilya University, Khandwa Road, Indore 452001, M. P., India 
Email: harshasharma0102@gmail.com 
Received: 20 Dec 2017 Revised and Accepted: 01 Feb 2018 
ABSTRACT 
Objective: The present study evaluates the antioxidant, anti-inflammatory and anti-atherosclerotic potency of taurine (2-amino ethane sulfonic 
acid) when administered orally to hypercholesterolemia induced atherosclerotic rats. 
Methods: The experimental atherosclerosis was induced by feeding rats with an atherogenic diet comprising of the normal rat chow supplemented 
with 4 % cholesterol, 1 % cholic acid and 0.5 % thiouracil (CCT diet) for 20 d. Treatment with atorvastatin (10 mg/kg body weight) and taurine (2 
% in drinking water) was given to atherosclerotic rats to study antioxidant enzymes (superoxide dismutase, catalase, glutathione-S-transferase), 
lipid peroxidation in liver, glutathione reductase and protein carbonyl content, extent of DNA damage using the alkaline comet assay, assaying pro-
inflammatory cytokines and quantifying atherosclerotic lesions. 
Results: Oral supplementation of 2 % taurine to hypercholesterolemic rats modulated antioxidant status and significantly reduced 
malondialdehyde (MDA) content (P<0.05). The extent of DNA damage was also significantly reduced as observed by a reduction in the comet tail 
index (P<0.05). Taurine exhibited anti-inflammatory activity by significantly inhibiting TNF-α (tumor necrosis factor) and IL-1α (inter leukine) and 
also inhibited atherosclerotic lesions by clearing lipid deposits on the intimal surface of the rat aorta. 
Conclusion: Oral administration of taurine to rats showed antioxidant and anti-inflammatory activity by modulating oxidants in favor of reducing 
oxidative stress and also showed anti-atherosclerotic activity in hypercholesterolemia-induced atherosclerosis. 
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One of a major health concern is hypercholesterolemia and is also the 
main cause of the development of cardiovascular diseases (CVD) [1]. 
Elevated blood lipid levels, such as total cholesterol (TC), triglyceride 
(TG), and low-density lipoprotein (LDL) and a decrease in high-density 
lipoprotein (HDL) are directly associated with hyperlipidemia and 
atherosclerosis [2]. Atherosclerosis is a chronic inflammatory disease, 
occurring due to prolonged hyperlipidemia. The pathogenesis includes 
endothelium damage followed by low-density lipoprotein-cholesterol 
(LDL-C) formation and its oxidation. Due to this monocyte reaching at 
the site, transform into macrophages and accumulate lipids leading to 
atherosclerotic plaques in the walls of the arteries. Evidence suggests 
that progression of atherosclerosis increase the risk of the production 
of reactive oxygen species (ROS) [3]. Increased ROS production results 
in oxidative damage to intracellular components. Oxidative damage of 
cells is protected by various enzymes and non-enzymatic antioxidant 
defence systems. The focus is being given to various natural dietary 
components for protecting the cells from these deleterious free 
radicals.  
In the present study, taurine (2-aminoethane sulfonic acid), a free 
intracellular amino acid was administered orally to rats. Taurine has 
been reported to regulate oxidative damage [4] and may, therefore, 
ameliorate prolonged hypercholesterolemia-induced athero-
sclerosis. Because of the unavailability of literature on the role of 
taurine in combating hypercholesterolemia induced athero-sclerotic 
damages, the present study was undertaken. The study included the 
evaluation of antioxidant enzymes such as superoxide dismutase 
(SOD), catalase (CAT), glutathione-s-transferase (GST), lipid 
peroxidation (LPO) glutathione reductase (GSH), protein carbonyl 
(PCO) content in liver, extent of DNA damage using the alkaline 
comet assay, assay of pro-inflammatory cytokines and quantifying 
atherosclerotic lesions in rat feed with high cholesterol diet-induced 
atherosclerosis.  
MATERIALS AND METHODS 
All the chemicals, reagents and organic solvents used in this study 
were of analytical grade. Taurine, agarose, Na-sarcocinate, triton-X 
100, dimethyl sulfoxide (DMSO), 2-thiouracil was procured from 
Himedia Laboratories Pvt Ltd, Mumbai, India, Atorvastatin tablets 
were procured from Lupin Pharmaceuticals Limited, Santacruz (East), 
Mumbai, India. Cholesterol, cholic acid was procured from SD Fine-
Chem Ltd. Pyrogallol and hydrogen peroxide were obtained from 
Merck India Ltd., Mumbai, India. Acetonitrile (ACN), ethylenediamine 
tetraacetic acid (EDTA) and 1,1,3,3-tetra ethoxy propane (TEP) were 
procured from Sigma-Aldrich, St. Louis, MO, USA. India. Sudan IV 
practical grade, streptomycin sulfate, guanidine hydrochloride was 
obtained from Loba Chemie Pvt. Ltd. Colaba, Mumbai, India. ELISA kits 
for TNF-α (tumor necrosis factor) and IL (inter leukine)-1α was 
purchased from Koma Biotech, Seoul, South Korea. 
Animals and diet 
Male albino rats of Wistar strain weighing about 200 g obtained from 
the Animal House Facility of DAVV Indore were kept in polypropylene 
cages (43 x 27 cm with a floor area of 165.85 cm2/animal) at an 
ambient temperature. Animals had free access to feed and water. The 
rats were acclimatized to the laboratory conditions for 10 d prior to 
initiation of the experiment. The experimental protocols were 
approved by the Institutional Animal Ethics Committee (IAEC) 
regulations approved by the committee for the purpose of control and 
supervision of experiments on animals (CPCSEA) (Reg. No. 
CPCSEA/2015/02 dt.4.7.2015) and conducted humanely. 
The animals were divided into four groups of six rats each. Group, I 
served as the control (cont). Rats in group II, III, and IV were fed 
with an atherogenic diet comprising of the normal rat chow 
supplemented with 4 % cholesterol, 1 % cholic acid and 0.5 % 
thiouracil (CCT diet) [5] for 20 d, Group II rats were 
hypercholesterolemic, Group III rats received atorvastatin (atorva) 
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(10 mg/kg) [6] and group IV rats received taurine (tau) (2 % in 
drinking water) [7] commencing 10 d after the start of the 
experimental period. At the end of the 20 d experimental periods, 
the blood samples were collected for alkaline comet assay and for 
detection of pro-inflammatory cytokines. The rats were sacrificed by 
decapitation and the liver and aortic tissues were quickly excised, 
washed with saline, blotted dry with a piece of filter paper and a 10 
% (w/v) homogenate in phosphate buffered saline (PBS) pH 7.4 was 
prepared to determine antioxidant enzymes and protein content. 
Sections of aorta were set aside in plaque detection processing.  
Estimation of serum cholesterol 
The estimation of serum cholesterol was performed by Sackett’s 
method as described by Varley (1976) [8]. 
Determination of malondialdehyde levels 
Malondialdehyde (MDA) content in liver was measured by HPLC 
method [9]. 
Determination of antioxidant status 
The activity of SOD [10], CAT [11], GST [12], GSH content [13] and 
PCO [14] in liver tissue were determined. 
Alkaline comet assay 
The break in DNA strands in blood leukocytes was measured using 
single cell gel electrophoresis [15, 16]. The slides were visualized using a 
fluorescent microscope (Olympus U-CMAD3) under 10x magnification. 
The quantification of the DNA strand breaks of the stored images was 
done using the software Comet score TM by which tail length, percent 
DNA in tail, tail moment, and olive moment were obtained directly. 
Measurement of proinflammatory cytokines 
Serum proinflammatory cytokines such as TNF-α and IL-1α were 
estimated by ELISA kits. 
Assessment of atherosclerotic lesions in the aorta  
Assessment of atherosclerotic changes in the aorta was performed 
by Sudan IV for lipid staining [17]. Photographs of the stained 
intimal surfaces of the aortas were taken using a digital camera. The 
digitized images were converted to TIFF file format using the 
software package Adobe Photoshop CS4 (Adobe Systems Inc, USA). 
The total and atherosclerotic areas of the intimal surfaces of the 
aortas were measured in pixels and square inches using NIH Image 
1.62. The extent of atherosclerotic lesions was expressed as a 
percentage of the total intimal surface area. 
Statistical analysis  
The data obtained were analyzed by the SPSS software package 
version 20. The mean values obtained for the different groups were 
compared by one-way ANOVA, followed by post hoc-Tukeys (HSD) 
test and P<0.05 were considered significant. 
RESULTS 
Effect of taurine treatment on serum cholesterol 
CCT diet significantly increased serum cholesterol levels in 
hypercholesterolemic rats (Group II) on day 0, 10 and 20 of 
treatment as compared to control (Group I) (table 1). Treatment 
with 2 % taurine (Group IV) significantly lowered serum cholesterol 
on day 20 as compared to Group II. 
 
Table 1: Effect of taurine treatment on serum cholesterol (mg %) 
Group Cholesterol Day 0 Cholesterol Day 10 Cholesterol Day 20 
I Cont  81.80±0.86  84.40±0.92  89.00±5.96 
II Hyperchol  87.40±0.67** 199.80±1.28** 421.80±24.59** 
III Atorva 86.20±0.48**  272.60±6.96**## 264.80±7.08**## 
IV Tau 90.60±0.24**  218.40±11.20**  248.20±26.10**## 
Values are mean±SEM of 6 animals. The data were analyzed by one-way ANOVA, followed by post hoc-Tukeys (HSD) test. *P<0.05; **P<0.01 as 
compared to Group I, #P<0.05; ##P<0.01 as compared to Group II. 
 
Effect of taurine on atherogenic diet-induced lipid peroxidation 
in rat liver 
Results showed that LPO in the liver of atherogenic diet-induced 
hypercholesterolemic rats (Group II) was significantly higher as 
compared to the control (Group I) (table 2). A significant decrease in 
liver LPO was observed in rats treated with atorvastatin and taurine 
(Groups III and IV) as compared to hypercholesterolemic rats (Group II).  
Effect of taurine on SOD and CAT activity of rat liver  
The liver SOD activity was significantly decreased in 
hypercholesterolemic rats (Group II) as compared to control 
(Group I). However, treatment with standard drug atorvastatin 
(Group III) and taurine (Group IV) did not show a significant 
increase in liver SOD activity as compared to 
hypercholesterolemic rats (Group II).  
The liver CAT activity was significantly decreased in 
hypercholesterolemic rats (Group II) rats as compared to control 
(Group I). Treatment with standard drug atorvastatin (Group III) 
showed a significant increase in the liver CAT as compared to 
hypercholesterolemic rats (Group II) (table 2). Treatment with 
taurine (Group IV) however, showed a non-significant increase in 
CAT activity as compared to hypercholesterolemic rats (Group II). 
 
Table 2: Effect of taurine treatment on LPO and antioxidant enzymes in liver of rats 




CAT(µmol H2O2 decomposed/min/mg 
protein) 
I Cont  0.09±0.01 19.66±1.14 460.00±56.36 
II Hyperchol 0.51±0.03**  9.26±1.05**  263.20±9.35** 
III Atorva  0.23±0.01*##  15.12±0.50 402.40±23.10# 
IV Tau 0.11±0.02##  9.62±0.25**  347.20±20.74 
Values are mean±SEM of 6 animals. *P<0.05; **P<0.01significant as compared to Group I. #P<0.05; ##P<0.01significant as compared to Group II.  
 
Effect of taurine on GST, GSH and PCO content in rat liver 
Liver GST activity was significantly increased in hypercholesterolemic 
rats (Group II) as compared to control (Group I). Treatment with 
atorvastatin (Group III) showed a decrease in liver GST as compared 
to hypercholesterolemic rats (Group II) (table 3). Taurine treatment 
(Group IV) however, showed no effect on GST activity in the liver as 
compared to hypercholesterolemic rats (Group II).  
GSH content was found significantly decreased in 
hypercholesterolemic rats (Group II) as compared to control rats 
(Group I). Treatment with atorvastatin (Group III) showed no 
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significant change in liver GSH as compared to hypercholesterolemic 
rats (Group II) (table 3). However, a significant increase in liver GSH 
content was observed with taurine treatment (Group IV) as 
compared to hypercholesterolemic rats (Group II) (table 3).  
PCO content was significantly increased in hypercholesterolemic 
rats (Group II) as compared to control rats (Group I). Atorvastatin 
(Group III) and taurine treatment (Group IV) showed no significant 
change in PCO as compared to hypercholesterolemic rats (Group II). 
 
Table 3: Effect of taurine on GST, GSH and PCO content in rat liver 
Group GST (µmol GSH conjugated/min/mg 
protein) 
GSH (µmol DTNB conjugated/mg 
protein) 
PCO(nmol of carbonyl formed/mg 
protein) 
I Cont  1.12±0.09  34.80±2.39  0.021±0.001 
II Hyperchol  2.10±0.14** 15.60±1.07**  0.047±0.004** 
III Atorva 1.53±0.21 18.80±2.08**  0.032±0.001 
IV Tau  2.16±0.04* 37.00±2.82##  0.040±0.001** 
Values are mean±SEM of 6 animals. *P<0.05; **P<0.01 significant as compared to Group I. #P<0.05; ##P<0.01 significant as compared to Group II.  
 
DNA damage using single cell gel electrophoresis (comet assay) 
The genoprotective effect of taurine against ROS in peripheral blood 
leukocytes of hypercholesterolemic rats was evaluated using single 
cell gel electrophoresis and has been presented in fig. 1 and in table 
4. Results indicate that the nuclear DNA was confined to their 
position in a compact form in the control group (Group I). The 
hypercholesterolemic group (Group II) showed significantly 
increased comet parameters such as tail DNA %, tail length (L), tail 
moment (TM) and olive tail moment (OTM) as evaluated against 
control. Atorvastatin treatment (Group III) showed a significant 
reduction in the comet tail index, tail DNA %, tail moment and olive 
tail moment as compared to hypercholesterolemic rats (Group II). 
Taurine treatment (Group IV) also showed a significant reduction in 
the comet tail index, tail DNA %, tail moment and olive tail moment 
as compared to hypercholesterolemic rats (Group II). 
 
 
Fig. 1: Effect of taurine treatment on hypercholesterolemia induced DNA damage in peripheral blood leukocytes by comet assay 
 
 Table 4: Effect of taurine treatment on hypercholesterolemia induced DNA damage in peripheral blood leukocytes on various 
comet parameters 
  L Comet µm L Head µm L Tail µm Head DNA % Tail DNA % TM µm OTM µm 
I Cont 26.80±0.80 23.80±0.80 3.00±0.00 99.11±0.29 0.88±0.29 0.02±0.01 0.10±0.03 
II Hyperchol 58.80±3.63** 33.00±2.75 25.80±1.68** 77.54±0.59** 22.44±0.59** 5.77±0.36** 5.21±0.39** 
III Atorva 47.20±1.65* 42.60±1.60** 4.60±0.50** 97.43±0.68## 2.42±0.62## 0.18±0.06## 0.46±0.11## 
IV Tau 37.60±2.82# 33.00±2.82 4.60±0.40## 95.46±0.85## 4.52±0.85## 0.19±0.05## 0.52±0.06## 
Values are mean±SEM, n = 50, L=length, *P<0.05; **P<0.01 significant as compared to Group I. #P<0.05; ##P<0.01 significant as compared to Group II.  
 
Determination of proinflammatory cytokines 
The effect of taurine treatment on serum proinflammatory cytokines 
such as TNF-α and IL-1α were evaluated using ELISA method and 
has been shown in fig. 2. The hypercholesterolemic rats (Group II) 
showed a significant increase in serum TNF-α and IL-1α as 
compared to control (Group I). Treatment with atorvastatin and 
taurine (Group III and IV) showed significant inhibition of serum 




Fig. 2: Effect of taurine treatment on serum pro-inflammatory cytokines, values are mean±SEM, n = 6. *P<0.05; **P<0.01 significant as 
compared to group I, #P<0.05; ##P<0.01 significant as compared to group II 
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Atherosclerotic lesions in the aorta 
A representative photograph of atherosclerotic changes in the 
internal surfaces of aortas from the four groups of rats, stained with 
Sudan IV is shown in fig. 3 and the extent of atherosclerotic lesions 
in these groups is summarized in fig. 4. There were no athero-
sclerotic lesions in the aortas of Group I. However, significant areas 
of the intimal surfaces of aortas from Group II were covered with 
atherosclerotic plaques.  
Group III and Group IV showed a very low amount of atherosclerotic 
plaques, indicating recovery after treatment in these groups. 
 
 
Fig. 3: Representative photographs of the intimal surfaces of aortas of the four groups, stained with sudan IV. The lipid deposits on the 
internal surfaces of the aortas are shown in brick red color 
 
 
Fig. 4: Quantification of plaque deposition on intimal surfaces of aorta, Values are mean±SEM, n = 6. *P<0.05; **P<0.01 = significant as 
compared to Group I and #P<0.05; ##P<0.01 = significant as compared to group II 
 
DISCUSSION 
Studies have shown that elevated serum TC and LDL-C 
concentrations, promote atherosclerosis and cardiovascular 
complications [18]. Oxidative modification of LDL-C has been shown 
to initiate the progression of atherogenic changes in aorta [3, 19]. 
This has prompted the study of antioxidants in the prevention and 
progression of CVD.  
The results show that hypercholesterolemia leads to increase in 
tissue LPO. Similar findings were also observed in other studies [20, 
21]. The increase in liver LPO in the hypercholesterolemic group as 
compared to control was due to increased oxidative stress and 
cellular damage. However, the decrease in LPO observed in taurine-
treated animals, suggest that taurine strengthen the antioxidant 
defence system and prepared the animals to withstand the damaging 
effects of hyperlipidemic state. The decrease in cholesterol content 
along with its LDL fraction could also be due to increased cholesterol 
excretion and decreased cholesterol absorption through the 
gastrointestinal tract [22]. The decrease in liver SOD, CAT and GSH 
content in hypercholesterolemic rats was probably due to free 
radicals induced inhibition of antioxidant enzymes in high 
cholesterol-fed animals.  
The GSH content significantly decreased in the liver of animals fed 
high-cholesterol diet as compared to the control diet group 
indicating oxidative stress due to CCT diet. This observation is 
consistent with the administration of high cholesterol in 
experimental rats [23]. A significant increase in GSH content in 
taurine administered rats suggests that taurine facilitates the 
removal of free radicals and may enhance the repairing of the 
endogenous antioxidant system due to oxidative stress. 
Protein carbonyl is the widely used biomarker for oxidative damage 
to proteins by various ROS [24]. Studies have suggested that the 
accumulation of oxidized proteins is associated with progression of 
atherosclerosis [25]. However, in the present study, no significant 
change was observed in liver PCO content with the taurine 
administration in hypercholesterolemic rats.  
Lymphocyte DNA damage is also one of the reliable markers to 
detect oxidative stress [26, 27]. It has been shown that increased 
DNA damage in hypercholesterolemia was caused by the increased 
production of ROS and decreased antioxidative capacity [28], which 
ultimately leads to the significant development and the progression 
of atherosclerosis [29, 30]. The present study showed the primary 
DNA damage in leukocytes of atherosclerotic animals. 
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 Administration of taurine conferred significant protection against 
lymphocyte DNA damage, may be due to its free radical scavenging 
activity.  
Pro-inflammatory cytokines such as TNF-α and IL-6 are considered 
good predictors of CVD [31]. In the present investigation, high-fat 
diet-induced hypercholesterolemic animals showed increased levels 
of serum proinflammatory cytokines such as TNF-α and IL-1α. 
Taurine significantly reduces the serum concentration of these 
cytokines, indicating the anti-inflammatory property of taurine. The 
studies reviewed by Berg and Scherer have demonstrated that 
increase in the inflammatory markers such as IL-6 and TNF-α may 
translate to accelerated atherogenesis [32]. Induction of these 
cytokine gene expressions is regulated by a common pathway, ie, 
activation of nuclear factor-κB (NF-κB) signalling [33, 34]. Studies 
have shown that taurine chloramines inhibit inflammatory 
responses within the atherosclerotic lesions by inhibiting NF-κB 
activity in vascular smooth muscle cells and mononuclear cells [35]. 
Other studies also indicate that taurine treatment significantly 
reduced atherosclerotic lesions in the aorta of hypercholesterolemic 
rats [36]. It is proposed that recovery in atherosclerosis by taurine 
in rats may be related to the antioxidative and the DNA repair 
properties of taurine. 
CONCLUSION 
The current investigation focuses on the role of administration of 
taurine as a potent antioxidant, as indicated by the preventive action 
of lipids and protein oxidation, increase in liver GSH content and 
reduced DNA damage. The anti-inflammatory and anti-
atherosclerotic potential has been suggested to be attributed due to 
the antioxidant action of taurine.  
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